Furthermore, the monocarboxylate transporters 1 and 4 (MCT1 and MCT4, encoded by SLC16A1 and SLC16A3, respectively) that are typically overexpressed in glioblastomas, are underexpressed or silenced in glioblastomas that possess IDH1 mutations. Here, SLC16A3 is linked to glioblastoma.